Fasudil hydrochloride is a protein kinase inhibitor, i.e., an intracellular calcium ion antagonist, which dilates blood vessels and inhibits vasospasm by blocking the final stage of vasoconstriction (myosin light chain phosphorylation).

Quinolone is a broad-spectrum antibiotic that has bactericidal effects on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. It has good antibacterial effects on methicillin-resistant Staphylococcus aureus, ampicillin-resistant influenza bacilli, pipemidic acid-resistant Escherichia coli and bacteria resistant to other drugs. Its antibacterial mechanism is to inhibit the activity of bacterial DNA helicase, thereby inhibiting bacterial DNA transcription and replication, and has bactericidal effects on a variety of Gram-positive and Gram-negative bacteria.

Lomeza is a broad-spectrum quinolone antibiotic that has bactericidal effects on Gram-negative bacteria, Gram-positive bacteria and some anaerobic bacteria. It has good antibacterial effects on methicillin-resistant Staphylococcus aureus, ampicillin-resistant influenza bacilli, pipemidic acid-resistant Escherichia coli and bacteria resistant to other drugs. Its antibacterial mechanism is to inhibit the activity of bacterial DNA helicase, thereby inhibiting bacterial DNA transcription and replication, and has bactericidal effects on a variety of Gram-positive and Gram-negative bacteria.

Fructose metabolism can bypass the rate-limiting enzyme of glycolysis, fructose kinase, and has a faster metabolism rate, which can effectively reduce blood sugar fluctuations. Since the activity of fructokinase does not depend on the regulation of insulin, fructose can be metabolized into glycogen in the absence of insulin.

Glucose is metabolized more slowly than fructose and can provide energy sustainably. This product rarely relies on insulin for metabolism, and its energy utilization rate is significantly higher than that of monosaccharides. It can reduce the incidence of clinical ketoacidosis, and while providing energy quickly and fully, its impact on blood sugar level fluctuations is significantly lower than that of glucose.

Fructose metabolism can bypass the rate-limiting enzyme of glycolysis, fructose kinase, and has a faster metabolic rate, which can effectively reduce blood sugar fluctuations. Since the activity of fructokinase is not dependent on the regulation of insulin, fructose can be metabolized into glycogen in the absence of insulin. It can reduce the incidence of clinical ketoacidosis, and while providing rapid and sufficient energy, its impact on blood sugar level fluctuations is significantly less than that of glucose.

Glucose is metabolized more slowly than fructose and can provide sustainable energy. A comparative study of invert sugar and sucrose showed that there was no significant difference in blood glucose levels between the two groups of patients with normal and abnormal glucose tolerance after using invert sugar, and the increase in blood insulin levels in patients with abnormal glucose tolerance after using invert sugar was significantly less than that after using sucrose. Studies such as systemic allergy tests, hemolytic tests, and vascular irritation tests have shown that invert sugar injection is relatively safe and no adverse reactions were found.